跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Unbranded - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Unbranded
Approved
STANDARD
Unbranded
Hospira Australia Pty. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c3df09d3f39c1325
Company
Hospira Australia Pty. Ltd
Type
Standard
Approval Details
Approval Id
c3df09d3f39c1325
Drug Approval Philippines Name
Unbranded
Product Name
Unbranded
Registration Number
DR-XY730
Brand Name
Unbranded
Generic Name
Methotrexate
Dosage Form
Solution for Injection (IM/IV/Intrathecal/Intra-arterial)
Dosage Strength
25 mg/mL (50 mg/2 mL)
Manufacturer
Hospira Australia Pty. Ltd
Importer
Pfizer, Inc
Distributor
Pfizer, Inc.
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Distributor Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
25 April 2024
Expiry Date
08 June 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c3df09d3f39c1325
Type
Standard
Back to Philippines FDA Approvals